Correlations between levels of cartilage biomarkers and degree of RA disease activity (e.g., CRP, MMP-3, and DAS-28), radiographic progression (e.g., ΔJNS) and patient function (e.g., HAQ score) were investigated at weeks 22 and 54. Here, MMP3 is linked to rheumatoid arthritis.